Evaluation of Poly (1, 6-bis-(p-carboxyphenoxy) Hexane-co-sebacic Acid Microspheres for Controlled Basal Insulin Delivery

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2012 Sep 15

PMID 22975807

Authors

Chandrasekar Manoharan

Jagdish Singh

Affiliations

Soon will be listed here.

Abstract

Purpose: To develop poly 1,3-bis-(p-carboxyphenoxy) hexane-co-sebacic acid (p(CPH/SA)) microspheres for controlled basal insulin delivery and evaluate their in vivo efficacy and toxicity.

Methods: A series of CPH/SA copolymers with molar ratios 20/80, 40/60, and 50/50 were synthesized and characterized. The stability of encapsulated insulin and the fraction of insulin released from microspheres were assessed by different analytical techniques. The skin from the injection site of rats was examined microscopically for histomorphological changes.

Results: Increasing the molar ratio of CPH/SA significantly (p < 0.05) improved insulin loading and controlled insulin release. However, dimer aggregates of insulin were observed as CPH/SA molar ratio increased. Co-encapsulation of zinc oxide with insulin inhibited dimer aggregate formation and further controlled insulin release. Insulin was stable after entrapment into microspheres and during in vitro release studies. Administration of microsphere formulations CPH/SA 40/60 and 50/50 with zinc oxide controlled insulin release and maintained basal insulin levels for 42 days in rats. Skin sections showed minimal inflammation with no evidence for histomorphological changes and toxicity.

Conclusions: Insulin-loaded CPH/SA microspheres demonstrated considerable potential as controlled delivery system for insulin. Copolymer microspheres maintained basal insulin levels for 42 days and were biodegradable and biocompatible.

References

HALLAS-MOLLER K, Petersen K, SCHLICHTKRULL J . Crystalline and amorphous insulin-zinc compounds with prolonged action. Science. 1952; 116(3015):394-8. DOI: 10.1126/science.116.3015.394. View

Rosa G, Iommelli R, La Rotonda M, Miro A, Quaglia F . Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J Control Release. 2000; 69(2):283-95. DOI: 10.1016/s0168-3659(00)00315-1. View

Kang F, Singh J . Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbits. AAPS PharmSciTech. 2005; 6(3):E487-94. PMC: 2750395. DOI: 10.1208/pt060361. View

Duncan G, Jess T, Mohamed F, Price N, Kelly S, van der Walle C . The influence of protein solubilisation, conformation and size on the burst release from poly(lactide-co-glycolide) microspheres. J Control Release. 2005; 110(1):34-48. DOI: 10.1016/j.jconrel.2005.09.007. View

Tamada J, Langer R . The development of polyanhydrides for drug delivery applications. J Biomater Sci Polym Ed. 1992; 3(4):315-53. DOI: 10.1163/156856292x00402. View

Leong K, DAmore P, Marletta M, Langer R . Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. J Biomed Mater Res. 1986; 20(1):51-64. DOI: 10.1002/jbm.820200106. View

Jain J, Chitkara D, Kumar N . Polyanhydrides as localized drug delivery carrier: an update. Expert Opin Drug Deliv. 2008; 5(8):889-907. DOI: 10.1517/17425247.5.8.889. View

Manoharan C, Singh J . Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability. J Pharm Sci. 2008; 98(2):529-42. DOI: 10.1002/jps.21445. View

Manoharan C, Singh J . Evaluation of polyanhydride microspheres for basal insulin delivery: Effect of copolymer composition and zinc salt on encapsulation, in vitro release, stability, in vivo absorption and bioactivity in diabetic rats. J Pharm Sci. 2009; 98(11):4237-50. DOI: 10.1002/jps.21741. View

10.

Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M . Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150(1):76-85. DOI: 10.1016/0003-2697(85)90442-7. View

11.

Shao P, Bailey L . Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics. Pharm Dev Technol. 2000; 5(1):1-9. DOI: 10.1081/pdt-100100513. View

12.

Peppas N, Langer R . New challenges in biomaterials. Science. 1994; 263(5154):1715-20. DOI: 10.1126/science.8134835. View

13.

Determan A, Trewyn B, Lin V, Nilsen-Hamilton M, Narasimhan B . Encapsulation, stabilization, and release of BSA-FITC from polyanhydride microspheres. J Control Release. 2004; 100(1):97-109. DOI: 10.1016/j.jconrel.2004.08.006. View

14.

Weiner A, Bock E, Gipson M, Shastri V . Photocrosslinked anhydride systems for long-term protein release. Biomaterials. 2008; 29(15):2400-7. DOI: 10.1016/j.biomaterials.2008.01.013. View

15.

Sah H . Protein behavior at the water/methylene chloride interface. J Pharm Sci. 1999; 88(12):1320-5. DOI: 10.1021/js9900654. View

16.

Quaglia F, De Rosa G, Granata E, Ungaro F, Fattal E, La Rotonda M . Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. J Control Release. 2003; 86(2-3):267-78. DOI: 10.1016/s0168-3659(02)00414-5. View

17.

Mollmann S, Bukrinsky J, Frokjaer S, Elofsson U . Adsorption of human insulin and AspB28 insulin on a PTFE-like surface. J Colloid Interface Sci. 2005; 286(1):28-35. DOI: 10.1016/j.jcis.2005.01.018. View

18.

Furtado S, Abramson D, Simhkay L, Wobbekind D, Mathiowitz E . Subcutaneous delivery of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats. Eur J Pharm Biopharm. 2006; 63(2):229-36. DOI: 10.1016/j.ejpb.2005.12.012. View

19.

Shaw J, Sicree R, Zimmet P . Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009; 87(1):4-14. DOI: 10.1016/j.diabres.2009.10.007. View

20.

Jiang H, Zhu K . Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes. Int J Pharm. 1999; 194(1):51-60. DOI: 10.1016/s0378-5173(99)00336-1. View